FDA approves Celgene's bone marrow cancer treatment
August 16, 2019 at 09:58 AM EDT
The U.S. Food and Drug Administration said on Friday it had approved Celgene Corp's treatment, Inrebic, for certain forms of bone marrow cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|